One giant leap for cephalexin dosing, one small step for antimicrobial stewardship

CJEM. 2023 Jan;25(1):7-8. doi: 10.1007/s43678-022-00442-6.

Authors

Paul Ken Leong Chin^{1

2}, Martin Than³, Stephen Chambers⁴

Affiliations

¹ Department of Medicine, University of Otago, Private Bag 4345, Christchurch, New Zealand. paul.chin@otago.ac.nz.
² Department of Clinical Pharmacology, Te Whatu Ora Health New Zealand, Waitaha Canterbury, Christchurch, New Zealand. paul.chin@otago.ac.nz.
³ Emergency Department, Christchurch Hospital, Christchurch, New Zealand.
⁴ Department of Pathology, University of Otago, Christchurch, New Zealand.

PMID: 36617614
DOI: 10.1007/s43678-022-00442-6

No abstract available

Keywords: Cellulitis; Cephalexin; Emergency department; Pharmacokinetics.

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antimicrobial Stewardship*
Cephalexin*
Humans
Trimethoprim, Sulfamethoxazole Drug Combination

Substances

Cephalexin
Anti-Bacterial Agents
Trimethoprim, Sulfamethoxazole Drug Combination